[20030627]RS21557_猴痘：生物恐怖主义防备的技术背景和疫情影响.pdf

Congressional Research Service The Library of CongressCRS Report for CongressReceived through the CRS WebOrder Code RS21557June 27, 2003Monkeypox: Technical Background andOutbreak Implications for BioterrorismPreparednessname redacted and name redactedAnalysts in Science and Technology PolicyResources, Science, and Industry Divisionname redactedSpecialist in Social LegislationDomestic Social Policy DivisionSummaryMonkeypox, a viral disease related to smallpox, has appeared in humans in theMidwest. Though monkeypox usually has a fatality rate of 1 to 10%, no fatalities haveoccurred in the outbreak, which has been linked to pet rodents. Although officials donot believe that this outbreak is bioterrorism, the delay between the initial presentationof an unusual disease and the notification to the federal government has raised concernsregarding the state of bioterrorism preparedness. The Centers for Disease Control andPrevention (CDC) have provided guidance to local communities regarding handling ofill patients and animals, treatment regimens, and sample protocols. The CDC haverecommended and released smallpox vaccine as prophylaxis against monkeypoxinfection. The CDC and the Food and D